Gastroesophageal Reflux is a Risk Factor for the Development of de novo Donor Specific Antibodies after Lung Transplantation.

IF 6.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Peter Bell, Jeffrey Kiernan, Rayoun Ramendra, Stella Wang, Ella Huszti, Frank D'Ovidio, Jonathan Yeung, Elliot Wakeam, Marcelo Cypel, Shaf Keshavjee, Stephen Juvet, Lianne Singer, Colleen Parker, Louis Liu, Tereza Martinu, Meghan Aversa
{"title":"Gastroesophageal Reflux is a Risk Factor for the Development of de novo Donor Specific Antibodies after Lung Transplantation.","authors":"Peter Bell, Jeffrey Kiernan, Rayoun Ramendra, Stella Wang, Ella Huszti, Frank D'Ovidio, Jonathan Yeung, Elliot Wakeam, Marcelo Cypel, Shaf Keshavjee, Stephen Juvet, Lianne Singer, Colleen Parker, Louis Liu, Tereza Martinu, Meghan Aversa","doi":"10.1016/j.healun.2025.03.007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite evidence that gastroesophageal reflux (GER) is harmful to the lung allograft, the mechanism of injury remains incompletely defined. We hypothesized that GER induces a humoral alloimmune response and examined the association between GER and de novo donor-specific antibody (DSA) development.</p><p><strong>Methods: </strong>508 lung transplant recipients who underwent routine pH-impedance testing at 3 months post-transplant were included. Univariable and multivariable Cox proportional hazards models were used to examine the impact of total GER events on de novo DSA development.</p><p><strong>Results: </strong>De novo DSA were detected in 230 subjects (45%) at a median of 69 days post-transplant. The highest tertile of GER events (≥19 events) was associated with a significantly increased risk of de novo DSA development compared to the lowest tertile (HR 1.4, 95% CI 1.00-1.91, p=0.05).</p><p><strong>Conclusion: </strong>GER is associated with de novo DSA development, which has implications for monitoring and anti-GER therapy after lung transplant.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart and Lung Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.healun.2025.03.007","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite evidence that gastroesophageal reflux (GER) is harmful to the lung allograft, the mechanism of injury remains incompletely defined. We hypothesized that GER induces a humoral alloimmune response and examined the association between GER and de novo donor-specific antibody (DSA) development.

Methods: 508 lung transplant recipients who underwent routine pH-impedance testing at 3 months post-transplant were included. Univariable and multivariable Cox proportional hazards models were used to examine the impact of total GER events on de novo DSA development.

Results: De novo DSA were detected in 230 subjects (45%) at a median of 69 days post-transplant. The highest tertile of GER events (≥19 events) was associated with a significantly increased risk of de novo DSA development compared to the lowest tertile (HR 1.4, 95% CI 1.00-1.91, p=0.05).

Conclusion: GER is associated with de novo DSA development, which has implications for monitoring and anti-GER therapy after lung transplant.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.10
自引率
6.70%
发文量
1667
审稿时长
69 days
期刊介绍: The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信